Skip to main content

Momentus Inc.

For the period ended Mar 31, 2026. Filed May 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

MNTS$1.90-5.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(in thousands)

Three Months EndedMarch 31,
20262025
Cash flows from operating activities:
Net loss$(9,480)$(6,172)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization328324
Amortization of debt (premium) and issuance costs480(315)
Amortization of right-of-use assets39659
Loss on disposal of fixed assets326—
Loss on debt extinguishment—(58)
Stock-based compensation expense3221,057
Change in fair value of convertible notes for legal services275—
Changes in operating assets and liabilities:
Accounts receivable(396)879
Prepaids and other current assets4,148(1,363)
Other non-current assets566153
Accounts payable(245)716
Accrued liabilities(28)(119)
Accrued interest24127
Other current liabilities31—
Contract liabilities(3,701)758
Operating lease liability(120)(191)
Litigation settlement contingency1,260—
Other non-current liabilities—(30)
Net cash used in operating activities(5,814)(4,175)
Cash flows from investing activities:
Purchases of property, machinery and equipment(197)—
Proceeds from sale of property, machinery and equipment12—
Net cash used in investing activities(185)—
Cash flows from financing activities:
Payment of convertible notes(783)(288)
Proceeds from exercise of warrants—2,068
Payments for issuance costs related to exercise of warrants—(179)
Repurchase of Section 16 Officer shares for tax coverage exchange—(1)
Proceeds from issuance of common stock, pre-funded warrants and related warrants18,3355,000
Payments for issuance costs related to common stock, pre-funded warrants and related warrants(826)(599)
Net cash provided by financing activities16,7266,001
Increase in cash, cash equivalents and restricted cash10,7271,826
Cash, cash equivalents, and restricted cash, beginning of period12,8611,572
Cash, cash equivalents, and restricted cash, end of period$23,588$3,398
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.